Executive Summary
Richard Staines spoke with Soren Bregenholt, the new CEO of Macrophage Pharma, about the company’s strategy encompassing both immune oncology and inflammatory diseases.
To read the full article, go on https://bit.ly/398smQc
Executive Summary
Richard Staines spoke with Soren Bregenholt, the new CEO of Macrophage Pharma, about the company’s strategy encompassing both immune oncology and inflammatory diseases.
To read the full article, go on https://bit.ly/398smQc